IFN-β1b (recombinant human)   

GtoPdb Ligand ID: 8340

Synonyms: Betaferon® | Betaseron® | Extavia® | IFNb1b
IFN-β1b (recombinant human) is an approved drug (FDA (1993), EMA (1995))
Comment: Compared to the sequence of endogenous IFN-β, IFN-β1b has a Ser to Cys substitution at position 17, but does not retain the glycosylation site at Asn80. It also lacks the initiating Met. This recombinant peptide is produced in E.coli.
Compound class Peptide or derivative
Approved drug? Yes (FDA (1993), EMA (1995))
International Nonproprietary Names
INN number INN
5380 interferon beta
Betaferon® | Betaseron® | Extavia® | IFNb1b
Database Links
Specialist databases
IMGT/mAb-DB 641
Other databases
DrugBank Ligand DB00068
GtoPdb PubChem SID 252166552
Search PubMed clinical trials interferon beta
Search PubMed titles interferon beta
Search PubMed titles/abstracts interferon beta
Wikipedia Interferon_beta_1b